English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Friday, October 16, 2020
TOT BIOPHARM International Company Limited Optimises Company Management Structure to Promote Strategic Development Upgrade
Wednesday, April 22, 2020
TOT BIOPHARM Self-Developed Biological Drug TAB008 (Pusintin) Meets Primary Endpoint in Phase III Clinical Trial
Wednesday, March 18, 2020
東曜藥業宣佈2019年全年業績
TOT BIOPHARM Announces 2019 Annual Results
Monday, March 9, 2020
TOT BIOPHARM Garners "Listing Award of Technological Company" and "Innovative Technological Research and Development Award"
東曜藥業榮獲科技企業上市獎和科技研發突出獎
Thursday, January 2, 2020
新年喜訊第一彈!東曜藥業(1875.HK)生物藥研發獲納入國家「重大新藥創制」科技重大專項
TOT BIOPHARM Biological Drug R&D Project Makes List of National Major Scientific and Technological Special Projects for "Significant New Drug Development"
Monday, December 16, 2019
東曜藥業獲納入「蘇州工業園區2019年度上市獎勵企業」名單
TOT BIOPHARM Included in the "Suzhou Industrial Park - 2019 Awarded Listed Enterprises"

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575